Skip to content
6-K

Foreign Interim / Material

Forward Pharma A/S

0001104659-22-116522

← back to feed
Filed
Nov 9, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2022 · Jun 30, 2022 99.02M sh
Shares Diluted Q2 2022 · Jun 30, 2021 97.26M sh
Operating Cash Flow Q2 2022 · Jun 30, 2022 $639K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$1.48M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $65.28M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $70.77M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $75.1M
Cash And Equivalents Q2 2022 · Dec 31, 2020 $79.09M
Stockholders Equity Q2 2022 · Jun 30, 2022 $62.08M
Stockholders Equity Q2 2022 · Dec 31, 2021 $70.8M
Stockholders Equity Q2 2022 · Jun 30, 2021 $75.11M
Stockholders Equity Q2 2022 · Dec 31, 2020 $78.64M
Current Liabilities Q2 2022 · Jun 30, 2022 $3.56M
Current Liabilities Q2 2022 · Dec 31, 2021 $608K
Current Assets Q2 2022 · Jun 30, 2022 $65.64M
Current Assets Q2 2022 · Dec 31, 2021 $71.4M
Total Assets Q2 2022 · Jun 30, 2022 $65.64M
Total Assets Q2 2022 · Dec 31, 2021 $71.41M
Eps Diluted Q2 2022 · Jun 30, 2022 $0.00
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.01
Eps Basic Q2 2022 · Jun 30, 2022 $0.00
Eps Basic Q2 2022 · Jun 30, 2021 −$0.01
Rd Expense Q2 2022 · Jun 30, 2022 $65K
Rd Expense Q2 2022 · Jun 30, 2021 $63K
Net Income Q2 2022 · Jun 30, 2022 $294K
Net Income Q2 2022 · Jun 30, 2021 −$1.03M
Operating Income Q2 2022 · Jun 30, 2022 −$1.82M
Operating Income Q2 2022 · Jun 30, 2021 −$1.82M